
Telzela-Beta 25 Tablet ER
Marketer
Zelaino Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Telzela-Beta 25 Tablet ER
CardioBeta 25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food daily, at the same time, as directed by your physician. Continue treatment as prescribed; high blood pressure is often asymptomatic, so discontinuation, even if feeling well, can worsen your condition. Lifestyle modifications including exercise, weight management, and a healthy diet further support blood pressure control. Adhere to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium, shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should consult their physician. Disclose all other medications, particularly those for hypertension or heart conditions.
Uses of Telzela-Beta 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telzela-Beta 25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Telzela-Beta 25 Tablet ER with a meal.
Common Side effects of Telzela-Beta 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telzela-Beta 25 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Telzela-Beta 25 Tablet ER with a meal.
How Telzela-Beta 25 Tablet ER works:
Telmisartan and Metoprolol Succinate are combined in the extended-release Telzela-Beta 25 Tablet to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telzela-Beta 25 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telzela-Beta 25mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telzela-Beta 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Telzela-Beta 25mg tablets can cause drowsiness, visual disturbances, and dizziness. Refrain from driving if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telzela-Beta 25 tablets are considered safe for patients with renal impairment. No dosage modification is necessary for Telzela-Beta 25 ER tablets in these individuals.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telzela-Beta 25 Extended-Release tablets. Dosage modification of Telzela-Beta 25 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Telzela-Beta 25 Tablet ER :
Should you forget a Telzela-Beta 25 Tablet ER dose, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Telzela-Beta 25 Tablet ER
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Heart |